Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

Authors

Ted M. Burns, University of Virginia
Gordon A. Smith, The University of Utah
Jeffrey A. Allen, University of Minnesota Medical School
Anthony A. Amato, Harvard Medical School
W. David Arnold, The Ohio State University
Richard Barohn, University of Kansas
Michael Benatar, University of Miami
Shawn J. Bird, University of Pennsylvania
Mark Bromberg, The University of Utah
Nizar Chahin, University of Connecticut
Emma Ciafaloni, University of Rochester
Jeffrey A. Cohen, Geisel School of Medicine at Dartmouth
Andrea Corse, Johns Hopkins School of Medicine
Brian A. Crum, Mayo Clinic
William S. David, Harvard Medical School
Elliot Dimberg, Mayo Clinic in Jacksonville, Florida
Eduardo A. De Sousa, University of Oklahoma
Peter D. Donofrio, Vanderbilt University
P. James B. Dyck, Mayo Clinic
Andrew G. Engel, Mayo Clinic
Erik R. Ensrud
Mark Ferrante, University of Tennessee Health Science Center
Miriam Freimer, The Ohio State University
Karissa L. Gable, Duke University
Summer Gibson, The University of Utah
James M. Gilchrist, Southern Illinois University School of Medicine
Jonathan M. Goldstein, Hospital for Special Surgery - New York
Clifton L. Gooch, University of South Florida, Tampa
Brent P. Goodman, Mayo Clinic Scottsdale-Phoenix, Arizona
Dmitri Gorelov, Crystal Run Healthcare
Sidney M. Gospe, University of Washington, Seattle

Document Type

Editorial

Publication Date

2-1-2016

Publication Title

Muscle and Nerve

ISSN

0148639X

E-ISSN

10974598

Volume

53

Issue

2

First Page

165

Last Page

168

PubMed ID

26662952

Digital Object Identifier (DOI)

10.1002/mus.25009

Recommended Citation

Burns, Ted M.; Smith, Gordon A.; Allen, Jeffrey A.; Amato, Anthony A.; Arnold, W. David; Barohn, Richard; Benatar, Michael; Bird, Shawn J.; Bromberg, Mark; Chahin, Nizar; Ciafaloni, Emma; Cohen, Jeffrey A.; Corse, Andrea; Crum, Brian A.; David, William S.; Dimberg, Elliot; De Sousa, Eduardo A.; Donofrio, Peter D.; Dyck, P. James B.; Engel, Andrew G.; Ensrud, Erik R.; Ferrante, Mark; Freimer, Miriam; Gable, Karissa L.; Gibson, Summer; Gilchrist, James M.; Goldstein, Jonathan M.; Gooch, Clifton L.; Goodman, Brent P.; Gorelov, Dmitri; and Gospe, Sidney M., "Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine" (2016). Neurology. 584.
https://scholar.barrowneuro.org/neurology/584